CTL公司*
细胞毒性T细胞
体内
CD8型
免疫学
生物
病毒学
癌症研究
体外
免疫系统
遗传学
作者
Kiyohiro Ando,Luca G. Guidotti,S Wirth,Tetsuya Ishikawa,Gabriele Missale,Takashi Moriyama,Robert D. Schreiber,H J Schlicht,S N Huang,Francis V. Chisari
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:1994-04-01
卷期号:152 (7): 3245-3253
被引量:200
标识
DOI:10.4049/jimmunol.152.7.3245
摘要
Abstract Although CD8-positive, class I-restricted CTL play a critical role in viral clearance and immunopathology in many model systems, they have not been shown to directly kill their target cells in vivo at the single cell level. Using a hepatitis B surface Ag transgenic mouse model of class I-restricted, CTL-mediated liver disease, we now demonstrate that CD8-positive, Ld-restricted hepatitis B surface Ag-specific CTL bind and kill their target cells in vivo by triggering them to undergo degenerative cytologic changes compatible with apoptosis. Unexpectedly, the data also indicate that the pathologic consequences of this direct, Ag-specific CTL effect are much less severe than the cytodestructive, Ag-nonspecific inflammatory response that they induce when they are activated by Ag recognition.
科研通智能强力驱动
Strongly Powered by AbleSci AI